[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"benign-skin-growth\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:benign-skin-growth":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,49],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100611941","developing-and-testing-the-effectiveness-of-a-skin-cancer-self-detection-educational-program-100611941",false,"NCT07247123","Developing and Testing the Effectiveness of a Skin Cancer Self-Detection Educational Program","Protocol for Developing and Testing the Effectiveness of a Skin Cancer Self-Detection Educational Program: A Randomised Controlled Trial","Inclusion Criteria:\n\n* Individuals aged 16 and above\n* Able to read and converse in English\n* Able to provide informed consent\n* Having the ability to use and interact with a web server or application.\n\nExclusion Criteria:\n\n\\- Individuals who have cognitive impairment or decline to participate. There will be no exclusion criteria based on a previous history of skin cancer.",true,"ALL","16 Years",{"count":20,"type":21},280,"ESTIMATED","INTERVENTIONAL",[24],"NA","Skin cancer is a significant public health concern, even in an Asian society like Singapore where it ranks among the top 10 cancers. This RCT tests the effectiveness of a skin cancer educational intervention to improve skin cancer outcomes among skin-of-color individuals, including the effects of gain versus loss framing.",[27,28,29],"Skin Cancer","Skin Cancer Prevention","Benign Skin Growth",[31,32,33,34,35],"skin cancer","skin cancer education","skin cancer intervention","patient education","digital education","RECRUITING","2026-06-29",{"date":39,"type":40},"2026-06-30","ACTUAL",{"date":42,"type":40},"2026-06-15",{"date":44,"type":21},"2027-12",{"name":46,"class":47},"National University Hospital, Singapore","OTHER",1,{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":16,"sex":17,"minAge":57,"maxAge":4,"enrollmentInfo":58,"targetDuration":4,"studyType":60,"phases":4,"briefSummary":61,"conditions":62,"keywords":64,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":48},"100608424","assessment-of-skin-lesions-using-a-tissue-oxygen-imager-based-on-protoporphyrin-ix-ppix-fluorescence-this-is-an-open-label-non-randomized-feasibility-study-that-includes-a-one-time-application-of-an-fda-approved-medication-followed-by-local-imaging-for-benign-skin-growth-and-lesions-clinically-100608424","NCT07201376","Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically","Tissue Oxygen Imager","PPIX","Inclusion Criteria:\n\n* Adults ≥ 18 years of age.\n* Histologic proof of non-melanoma skin cancer. Patients with different skin tones based on the Fitzpatrick Scale, who present with skin growth or lesions and are scheduled for resection.\n* As determined by the enrolling physician or study team member, the patient must have the willingness and ability to understand and comply with study procedures.\n* Women of childbearing potential (WOCBP): Premenopausal females who had at least one menstrual cycle in the past 12-months and capable to become pregnant, must have a negative serum beta-HCG pregnancy test result within seven days prior to start of study.\n* Lesions must measure between 5 mm and 3 cm in diameter.\n\nExclusion Criteria:\n\n* Patients who are \\\u003C18 years of age\n* Adults who are unable to provide informed consent.\n* Known allergy to Ameluz\n* Photosensitivity or photodermatoses or similar conditions.\n* Patients with any serious underlying medical condition that would impair their ability to receive or tolerate the planned treatment and\u002For comply with study protocol, in the opinion of the investigator\n* Known hypersensitivity to porphyrins or to any component of Ameluz, including soya bean phosphatidylcholine.\n* Females who are currently breast-feeding","18 Years",{"count":59,"type":21},125,"OBSERVATIONAL","The primary objective of this study is the evaluation of the efficacy of the tissue oxygen imager based on PpIX DF in differentiating benign skin growth from non-melanoma skin cancer (NMSC).",[63,29],"Non-Melanoma Skin Cancer (NMSC)",[29,65],"Non-Melanoma Skin Cancer","2026-02-04",{"date":68,"type":40},"2026-02-06",{"date":70,"type":40},"2025-11-14",{"date":72,"type":21},"2027-11",{"name":74,"class":47},"Dartmouth-Hitchcock Medical Center"]